Abstract
Radiosynovectomy (RSV) has been applied as an effective treatment to the patients with resistant synovitis for more than 50 years. In this research, 90Y-chitosan complex was developed as a new agent for use in RSV. 90Y was obtained from an electrochemical 90Y/90Sr generator. 90Y-chitosan complex was produced with radiochemical purity of higher than 99 % at the optimized condition. Extra-articular leakage of the complex was checked up to 72 h, which demonstrated excellent retention at the injection site. The complex showed significant characteristics which make it as a suitable agent for the management of synovitis.
Similar content being viewed by others
References
Jacobson DL, Gange SJ, Rose NR, Graham NM (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84:223–243
Markou P, Chatzopoulos D (2009) Yttrium-90 silicate radiosynovectomy treatment of painful synovitis in knee osteoarthritis. Results after 6 months. Hell J Nucl Med 12:33–36
Fischer M, Modder G (2002) Radionuclide therapy of inflammatory joint diseases. Nucl Med Commun 23:829–831
Fellinger K, Schmid J (1952) Local therapy of rheumatoid arthritis. Wien Z Inn Med 33:351
Ahlberg A, Pettersson H (1979) Synorviorthesis with radioactive gold in hemophiliacs. Clinical and radiological follow up. Acta Orthop Scand 50:513–517
Rivard GE, Girard M, Belanger R, Jutras M, Guay JP, Marton D (1994) Synoviorthesis with colloidal 32P chromic phosphate for the treatment of hemophilic arthropathy. J Bone Joint Surg Am 76:482–488
Kresnik E, Mikosch P, Gallowitsch HJ, Jesenko R, Just H, Kogler D, Gasser J, Heinisch M, Unterweger O, Kumnig G, Gomez I, Lind P (2002) Clinical outcome of radiosynoviorthesis: a meta-analysis including 2190 treated joints. Nucl Med Commun 23:683–688
Kavakli K, Aydogdu S, Omay SB, Duman Y, Taner M, Capaci K, Memiş A, Balkan C, Karapinar D (2006) Long-term evaluation of radioisotope synovectomy with Yttrium-90 for chronic synovitis in Turkish haemophiliacs: Izmir experience. Haemophilia 12:28–35
Calegaro JU, Machado J, De Paula JC, De Almeida JS, Casulari LA (2009) Clinical evaluation after 1 year of 153-samarium hydroxyapatite synovectomy in patients with haemophilic arthropathy. Haemophilia 15:240–246
Cho YJ, Kim KI, Chun YS, Rhyu KH, Kwon BK, Kim DY, Yoo MC (2010) Radioisotope synoviorthesis with Holmium-166-chitosan complex in haemophilic arthropathy. Haemophilia 16:640–646
Jahangier ZN, Jacobs JW, Van Isselt JW, Bijlsma JW (1997) Persistent synovitis treated with radiation synovectomy using yttrium-90: a retrospective evaluation of 83 procedures for 45 patients. Br J Rheumatol 36:861–869
Boussina I, Toussaint M, Ott H, Hermans P, Fallet GH (1979) A double-blind study of erbium-169 synoviorthesis in rheumatoid digital joints. Results after one year. Scand J Rheumatol 8:71–74
Jahangier ZN, Moolenburgh JD, Jacobs JW, Serdijn H, Bijlsma JW (2001) The effect of radiation synovectomy in patients with persistent arthritis: a prospective study. Clin Exp Rheumatol 19:417–424
Karavida N, Notopoulos A (2010) Radiation synovectomy: an effective alternative treatment for inflamed small joints. Hippokratia 14:22–27
Pirich C, Schwameis E, Bernecker P, Radauer M, Friedl M, Lang S, Kritz H, Wanivenhaus A, Trattnig S, Sinzinger H (1999) Influence of radiation synovectomy on articular cartilage, synovial thickness and enhancement as evidenced by MRI in patients with chronic synovitis. J Nucl Med 40:1277–1284
Teyssler P, Kolostova K, Bobek V (2013) Radionuclide synovectomy in haemophilic joints. Nucl Med Commun 34:291–297
Clunie G, Fischer M (2003) EANM procedure guidelines for radiosynovectomy. Eur J Nucl Med Mol Imaging 30:12–16
Kitonyi GW, Kitonyi JM (2009) Radiation synovectomy: treatment option for haemophilia patients with chronic haemarthrosis: a review. East Afr Med J 86:71–75
Thomas S, Gabriel MC, De Souza SAL, Gomes SC, Assi PE, Perri MLP, Liberato W, Matushita CS, Gutfilen B, Dafonseca LMB (2011) 90Yttrium-hydroxyapatite: a new therapeutic option for radioactive synovectomy in haemophilic synovitis. Haemophilia 17:985–989
Thomas S, Gabriel MB, Assi PE, Barboza M, Perri MLP, Land MGP, Da Costa ES (2011) Radioactive synovectomy with Yttrium-90 citrate in haemophilic synovitis: Brazilian experience. Haemophilia 22:211–216
Vuorela J, Sokka T, Pukkala E, Hannonen P (2003) Does yttrium radiosynovectomy increase the risk of cancer in patients with rheumatoid arthritis? Ann Rheum Dis 62:251–253
Report on the 2nd research coordination meeting on ‘The development of therapeutic radiopharmaceuticals based on 188Re and 90Y for radionuclide therapy’. Vienna, Austria 2010
Park KB, Kim JR, Lambrecht R (1996) Preparation of dysprosium-165/holmium-166 macroaggregate for radiation synovectomy. J Radioanal Nucl Chem 206:5–16
Ofluoglu S, Schwameis E, Zehetgruber H, Havlik E, Wanivenhaus A, Schweeger I, Weiss K, Sinzinger H, Pirich C (2002) Radiation synovectomy with (166)Ho-ferric hydroxide: a first experience. J Nucl Med 43:1489–1494
Shin K, Lee JC, Choi HJ, Jeong JM, Son M, Lee YJ, Lee EB, Hong SH, Song YW (2007) Radiation synovectomy using 188Re-tin colloid improves knee synovitis as shown by MRI in refractory rheumatoid arthritis. Nucl Med Commun 28:239–244
Harish KV, Prashanth RN (2007) Chitin/chitosan: modifications and their unlimited application potentiald-an overview. Trends Food Sci Technol 18:117–131
Rinaudo M (2006) Chitin and chitosan: properties and applications. Prog Polym Sci 31:603–632
Shirvani-Arani S, Bahrami-Samani A, Jalilian AR, Mazidi M, Afarideh H, Ghannadi-Maragheh M (2011) Preparation, quality control and biodistribution studies of 165Dy-chitosan for radiosynovectomy. Nukleonika 56:277–282
Zolghadri S, Jalilian AR, Yousefnia H, Bahrami-Samani A, Shirvani-Arani S, Mazidi M (2010) Production and quality control of Ho-166 chitosan for radiosynovectomy. Iran J Nucl Med 18:1–8
Shin BC, Park KB, Jang BS, Lim SM, Shim CK (2001) Preparation of 153Sm-chitosan complex for radiation synovectomy. Nucl Med Biol 28:719–725
Biological Council (1987) Guidelines on the use of living animals in scientific investigations. Biological Council, UK, 2nd edn
Chakravarty R, Pandey U, Manolkar RB, Dash A, Venkatesh M, Pillai MR (2008) Development of an electrochemical 90Sr-90Y generator for separation of 90Y suitable for targeted therapy. Nucl Med Biol 35:245–253
Pandey U, Dhami PS, Jagesia P, Venkatesh M, Pillai MRA (2008) Extraction paper chromatography technique for the radionuclidic purity evaluation of 90Y for clinical use. Anal Chem 80:801–807
Hirano S, Kodama N, Shibata K, Suzuki KT (1990) Distribution, localization, and pulmonary effects of yttrium chloride following intratracheal instillation into the rat. Toxicol Appl Pharmacol 104:301–311
Hirano S, Kodama N, Shibata K, Suzuki KT (1993) Metabolism and toxicity of intravenously injected yttrium chloride in rats. Toxicol Appl Pharmacol 121:224–232
Nakamura Y, Tsumura Y, Tonogai Y, Kanamoto M, Tsuboi N, Murakami K, Ito Y (1991) Studies on the biological effects of Rare Earth Elements: II. Distribution and the histological effects of Dy, Eu, Yb and Y in the rat after intravenous administration. Eisei Kagaku 37:489–496
Nakamura Y, Tsumura Y, Tonogai Y, Ito Y (1993) Studies on the biological effects of Rare Earth Elements: V. Relationship between the concentration of Rare Earth Elements and 9 minerals in various organs in the rat after intravenous administration of Dysprosium, Europium, Ytterbium and Yttrium by low or high dose. Jpn J Toxicol Environ Health 39:121–131
Bahrami-Samani A, Jalilian AR, Yousefnia H, Akhlaghi M, Mazidi M, Ghannadi-Maragheh M (2010) Development of Sm-153 Chitosan for Radiosynovectomy. Iran J Nucl Med 18:22–31
Davis MA, Chinol M (1989) Radiopharmaceuticals for Radiation Synovectomy: evaluation of Two Yttrium-90 Pariculate Agents. J Nucl Med 30:1047–1055
Gedik GK, Ugur O, Atilla B, Pekmezci M, Yildirim M, Seven B, Varogla E (2006) Comparison of extraarticular leakage values of radiopharmaceuticals used for radionuclide synovectomy. Ann Nucl Med 20:183–188
Song J, Suh CH, Park YB, Lee SH, Yoo NC, Lee JD, Kim KH, Lee SK (2001) A phase I/II a study on intra-articular injection of holimium-166-chitosan complex for the treatment of knee synovitis of rheumatoid arthritis. Eur J Nucl Med 28:489–497
Prabhakara G, Sachdeva SS, Umamaheswaria S, Sivaprasada N, Bhatiaa MH, Chaudharib PR, Solav SV (2007) Development of samarium [32P] phosphate colloid for radiosynoviorthesis applications: preparation, biological and preliminary clinical studies experience. Appl Radiat Isot 65:1309–1313
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zolghadri, S., Mirzaei, A., Athari-allaf, M. et al. Development of 90Y-chitosan as a new agent for radiosynovectomy. J Radioanal Nucl Chem 306, 47–55 (2015). https://doi.org/10.1007/s10967-015-4087-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-015-4087-4